Article metrics

Download PDFPDF

386 Phase I/Ib first-in-human study of HEK-NIZ985, a recombinant IL-15/IL-15Rα heterodimer, alone and in combination with spartalizumab, in adults with advanced and metastatic solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2020 to May 2022

AbstractFullPdf
Nov 2020406054
Dec 20206109
Jan 202161012
Feb 20216608
Mar 2021128019
Apr 202182010
May 202121018
Jun 20210028
Jul 20210016
Aug 20210012
Sep 20210012
Oct 202166014
Nov 2021138032
Dec 20218005
Jan 20223804
Feb 202238016
Mar 202264012
Apr 20224006
May 20227609
Total13650296